Projects

RNDr. Stanislava Jergová, PhD.

National

Finished
  • Neuroprotection in the process of ischemic tolerance acquisition from the perspective of rat brain pathways monitoring (proteomic MALDI-TOF/TOF study)
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2020
  • The role of glutamate transporters in blood cells in ischemic tolerance
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2020
  • Neuroprotective mechanisms of the AT2 receptor stimulation after traumatic spinal cord injury.
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2018
  • Impact of angiogenesis inhibition on postnatal neurogenesis
    Program: VEGA
    Duration: 1. 1. 2014 – 31. 12. 2016
  • A suppression of secondary injury of trauma-injured spinal cord using local hypothermia combined with local perfusion of neuroprotective substances
    Program: VEGA
    Duration: 1. 1. 2013 – 31. 12. 2015
  • Effects of anti-inflammatory treatment on traumatic spinal cord injury
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2013
  • Modulation somato-sensory neural pathways by Angiotensin II. Effect of Angiotensin II receptor blockade on nociceptive signaling.
    Program: VEGA
    Duration: 1. 1. 2010 – 31. 12. 2012
  • Causal genesis of experimentally-induced vibration syndrome.
    Program: VEGA
    Duration: 1. 1. 2008 – 31. 12. 2010
  • Spinal cord injury regeneration modulated by cell therapy
    Program: VEGA
    Duration: 1. 1. 2008 – 31. 12. 2010
  • Causal genesis of spasticity and therapeutic possibilities.
    Program: SRDA
    Duration: 7. 2. 2007 – 30. 6. 2010
  • Experimental transplantation of bone marrow stem cells, umbilical blood cord stem cells and spinal neural precursors for treatment of spinal cord injury.
    Program: SRDA
    Duration: 2. 5. 2006 – 30. 4. 2009
  • Distribution of spinal and supraspinal neuronal pools expressing nNOS and NK-1 receptor involved in chronic pain development
    Program: VEGA
    Duration: 1. 1. 2005 – 31. 12. 2007
  • The role of nitric oxide and substance p in the mechanisms of chronic pain and their pharmacological treatment.
    Program: SRDA
    Duration: 1. 2. 2005 – 31. 12. 2007
Employees